Allakos, Inc.

About

Allakos is a clinical-stage biotechnology company developing therapies to treat a variety of allergic and inflammatory diseases. Allakos is primarily focused on eosinophilic gastrointestinal disorders (EGIDs), leveraging industry-leading expertise in eosinophil and mast cell biology. The Company’s lead candidate, antolimab, is currently being tested in clinical trials across several gastrointestinal, skin and ophthalmic diseases.